Mineralys Therapeutics, a small drug developer, made a groundbreaking announcement on Monday regarding their experimental drug, lorundrostat. The company revealed that lorundrostat had shown significant promise in reducing blood pressure…

Subscribe Now for Real-time Updates on the Latest Stories!
The decision to cancel the terminations of the staff at the two world-class laboratories at the Centers for Disease Control…
In today's dating world, where apps and shifting gender norms dominate the landscape, emotionally intelligent men are emerging as the…
The One Big Beautiful Bill Act, if implemented, could have devastating consequences on the health care system in the United…
While claims of "Ozempic penis" may be circulating on social media, it's essential to take such assertions with a grain…
Humana's Strategy for Boosting Medicare Advantage Profitability A central theme in Humana’s plan for boosting Medicare Advantage profitability in the…
The disparities in mortality rates among American Indians and Alaska Natives (AI/AN) are much higher than previously reported in official…
Facial Recognition AI: The Rise of Stress-Tracking Skin Wearables In a world where technology continues to push boundaries, new waves…
The recent dismissal of all 17 experts from a government vaccine advisory panel has sparked controversy and concern among the…
Sign in to your account